Group 1 - Wall Street analysts expect Revvity (RVTY) to report quarterly earnings of $1.14 per share, reflecting a year-over-year decline of 6.6% [1] - Revenues are anticipated to be $711.27 million, which represents a 2.8% increase from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating a reassessment of projections by covering analysts [1] Group 2 - Analysts project 'Net Sales- Life Sciences' to reach $342.32 million, indicating a year-over-year increase of 9.1% [4] - The estimate for 'Net Sales- Diagnostics' is $365.99 million, reflecting a decline of 3.2% compared to the prior year [4] - Organic revenue growth for Diagnostics is expected to be 3.8%, up from 3.0% reported in the same quarter last year [5] Group 3 - Revvity shares have experienced a return of -0.3% over the past month, while the Zacks S&P 500 composite has increased by 5.9% [5] - Based on its Zacks Rank 3 (Hold), RVTY is expected to perform in line with the overall market in the near future [5]

In its upcoming report, FMC Technologies (FTI) is predicted by Wall Street analysts to post quarterly earnings of $0.36 per share, reflecting an increase of 63.6% compared to the same period last year. Revenues are forecasted to be $2.27 billion, representing a year-over-year increase of 11.1%. The consensus estimate for 'Revenue- Subsea Technologies' stands at $1.96 billion. The estimate suggests a change of +13% year over year. Analysts forecast 'Inbound Orders - Subsea Technologies' to reach $2.47 billio ...